Abstract
Objective: Sexual dysfunctions are increasing day by day. Various formulations are available for the treatment of same. There has been psychological mind-set among Indian patients to have powdered medicines for the sexual dysfunction management. The aim of this study was to analyze the preferred formulation by the patients for the treatment sexual dysfunction.
Methods: A cross-sectional and observational study was undertaken from January 2018–January 2019 in psychiatry OPD of a tertiary care teaching institute after approval from the Institutional Ethics Committee. A semi-structured questionnaire was made collecting information on demographic details and preferred pharmaceutical formulations for the treatment of sexual dysfunctions.
Results: Out of 164 participants who were analyzed, the most common age group having sexual dysfunctions was found to be 21–30 years (44%). Patients preferred Ayurvedic form of treatment (38.41%) over Allopathic (23.17%). Patients were in favor of SOS medications (51.83%) than day or night doses. Majority of the patients wanted drugs in tablet form (67.07%), in monthly doses (43.9%), of white color (39.02%), along with water (54.88%) and at <Rs.100 per strip (67.07%).
Conclusions: Majority of the patients prefer Ayurvedic form of treatment and SOS, on monthly basis, white colored tablets, taken with water at affordable prices. These factors need to be kept in mind while formulating new drugs and guidelines to ensure better compliance.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference11 articles.
1. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57. doi: 10.1038/sj.ijir.3901250, PMID 15215881
2. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-6. doi: 10.1046/j.1464- 410x.1999.00142.x, PMID 10444124
3. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000;2:189-95. doi: 10.1007/s11920- 996-0006-2, PMID 11122954
4. Hackett GI. Patient preference in treatment of erectile dysfunction: The continuing importance of patient education. Clin Cornerstone 2005;7:57-65. doi: 10.1016/s1098-3597(05)80049-3, PMID 16156424
5. Sample Size Calculator-Confidence Level, Confidence Interval, Sample Size, Population Size, Relevant Population. Creative Research Systems. Available from: https://www.surveysystem.com/sscalc.htm